MYC and cancer: Treatment with low micromolar concentrations of the ~ 10 kDa Omomyc protein has led to significant antiproliferative responses in cancer cells with amplified c-Myc levels (lymphoma, colon and lung cancer), promoting c-Myc transcriptional shutdown in a similar fashion as described for its transgenic vector.